Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
RSC Chemical Biology
|
July 22, 2022
Monitoring GAPDH activity and inhibition with cysteine-reactive chemical probes
Sarah E Canarelli, Brooke M Swalm, Eric T Larson, et al.
The Biochemical Journal
|
May 18, 2013
Convergent evolution of chromatin modification by structurally distinct enzymes: comparative enzymology of histone H3 Lys²⁷ methylation by human polycomb repressive complex 2 and vSET
Brooke M Swalm, Kenneth K Hallenbeck, Christina R Majer, et al.
ACS Chemical Biology
|
August 26, 2014
Reaction coupling between wild-type and disease-associated mutant EZH2
Brooke M Swalm, Sarah K Knutson, Natalie M Warholic, et al.
Cancer Discovery
|
April 8, 2024
The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers
Meagan B Ryan, Bradley Quade, Natasha Schenk, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
RSC Chemical Biology
|
July 22, 2022
Monitoring GAPDH activity and inhibition with cysteine-reactive chemical probes
Sarah E Canarelli, Brooke M Swalm, Eric T Larson, et al.
The Biochemical Journal
|
May 18, 2013
Convergent evolution of chromatin modification by structurally distinct enzymes: comparative enzymology of histone H3 Lys²⁷ methylation by human polycomb repressive complex 2 and vSET
Brooke M Swalm, Kenneth K Hallenbeck, Christina R Majer, et al.
ACS Chemical Biology
|
August 26, 2014
Reaction coupling between wild-type and disease-associated mutant EZH2
Brooke M Swalm, Sarah K Knutson, Natalie M Warholic, et al.
Cancer Discovery
|
April 8, 2024
The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers
Meagan B Ryan, Bradley Quade, Natasha Schenk, et al.
Journal of Medicinal Chemistry
|
March 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider, et al.
Page
of 1